Abstract
CONVENTIONAL wisdom and treatment may have to give way as new evidence suggests that glaucoma treatments may be aimed the wrong way. Future therapy will likely be designed to clean out the trabecular meshwork encircling the cornea to allow fluid out, rather than to reduce the flow into the eye as most current treatments do. So suggest findings presented at a Research to Prevent Blindness science writers seminar in Universal City, Calif. If theory is confirmed in an ongoing phase III multicenter trial, one new treatment aimed at the trabecular meshwork may be needed as infrequently as once a year, predicts one researcher. "We know unequivocally that for all forms of glaucoma, it is not a disease of excess formation of fluid, it is a disease of impaired drainage," says David L. Epstein, MD, professor and chair of ophthalmology, Duke University Medical Center, Durham, NC. Ted S. Acott, PhD, another
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
